Opinion | Will Obesity Drugs Change the Bariatric Surgery Landscape?
Mark Twain once said, “History never repeats itself, but it does often rhyme.” As a weight-loss surgeon for over 20 years, I have witnessed the new obesity medications with both anticipation and nostalgia. Just like bariatric surgery experienced a generation ago, we are now hearing the same refrains for obesity medications move from excitement to […]
Opinion | Annual Check-Up: Mark Cuban’s Cost Plus Drugs
On February 16, 2022, medical student Jared Dashevsky shared his perspective on Mark Cuban’s new business endeavor, the Cost Plus Drug Company. As part of MedPage Today‘s review of the past year’s top events, Dashevsky follows up with his thoughts on how the company is doing nearly 1 year post-launch and where it may be […]
Opinion | Will Elon Musk’s Warning About the Future Hold True for Medicine?
“Mark my words. AI [artificial intelligence] is more dangerous than nukes.” — Elon Musk The other day, as soon as I walked into work, already running my usual 10 minutes late, I was hustling from my office to the clinic when I saw one of our physician assistants in the hallway. She is otherwise known […]
Kansas State Senator Implies Bill on Controversial COVID Therapies Passed
In a letter sent to hospitals and healthcare clinics earlier this week, Mark Steffen, MD, a state senator from Kansas, seemed to suggest a bill that would remove restrictions on the use of treatments like ivermectin and hydroxychloroquine for COVID-19 had already passed. “With the recent passage of Senate substitute for HB 2280 … there […]